A Randomized Trial of an Exclusive Human Milk Diet in Neonates with Single Ventricle Physiology

Abstract

To determine whether weight gain velocity (g/kg/day) 30days after the initiation of feeds after cardiac surgery and other clinical outcomes improve in infants with single ventricle physiology fed an exclusive human milk diet compared with a mixed human and bovine diet. In this multicenter, randomized, single blinded, controlled trial, term neonates 7days of age or younger with single ventricle physiology and anticipated cardiac surgical palliation within 30days of birth were enrolled at 10 US centers. Both groups received human milk if fed preoperatively. During the 30days after feeds were started postoperatively, infants in the intervention group received human milk fortified once enteral intake reached 60mL/kg/day with a human milk-based fortifier designed for term neonates. The control group received standard fortification with formula once enteral intake reached 100mL/kg/day. Perioperative feeding and parenteral nutrition study algorithms were followed. We enrolled 107 neonates (exclusive human milk=55, control=52). Baseline demographics and characteristics were similar between the groups. The median weight gain velocity at study completion was higher in exclusive human milk vs control group (12g/day [IQR, 5-18g/day] vs 8g/day [IQR, 0.4-14g/day], respectively; P=.03). Other growth measures were similar between groups. Necrotizing enterocolitis of all Bell stages was higher in the control group (15.4 % vs 3.6%, respectively; P=.04). The incidence of other major morbidities, surgical complications, length of hospital stay, and hospital mortality were similar between the groups. Neonates with single ventricle physiology have improved short-term growth and decreased risk of NEC when receiving an exclusive human milk diet after stage 1 surgical palliation. This trial is registered with ClinicalTrials.gov (www. gov, Trial ID: NCT02860702).